期刊文献+

GLUT_1介导的脑靶向去甲文拉法辛前药的设计与合成 被引量:1

Design and synthesis of GLUT_1 mediated brain targeting prodrug of desvenlafaxine
原文传递
导出
摘要 目的合成一种由葡萄糖转运蛋白1(GLUT1)介导的脑靶向去甲文拉法辛前药。方法将苄基保护的去甲文拉法辛与己二酸单叔丁酯在缩合剂DCC作用下成酯Ⅱ,经三氟乙酸脱除叔丁基保护后,再与1,2,3,4-四-O-三甲硅基-α-D-吡喃葡萄糖在缩合剂DCC的作用下成酯,在酸性条件下脱除三甲硅基保护,最后催化氢化脱除苄基保护得到目标化合物。结果与结论合成了目标化合物脑靶向去甲文拉法辛前药;目标化合物及重要中间体均经1HNMR和MS确证。 OBJECTIVE To synthesize a brain targeting prodrug of desvenlafaxine mediated by glucose transporter 1(GLUT1).METHODS Desvenlafaxine protected by benzyl group was coupled with mono t-butyl adipic acid to afford compound Ⅱ,which was deprotected by trifluoroacetic acid to afford acid Ⅲ.Then compound Ⅲ was coupled with 1,2,3,4-tetra-O-trimethylsilyl-α-D-glucopyranose in the presence of DCC and DMAP to get compound Ⅳ,which was deprotected by acid to obtain compound Ⅴ.Deprotection of compound Ⅴ by H2/Pd furnished the target compound Ⅵ.RESULTS and CONCLUSION The target compound was successfully synthesized.The chemical structure of the target compound and intermediates were characterized by 1HNMR and MS.
出处 《华西药学杂志》 CAS CSCD 北大核心 2012年第2期118-120,共3页 West China Journal of Pharmaceutical Sciences
基金 国家自然科学基金资助项目(批准号:81072532) 教育部优先资助领域项目(批准号:20110181130011)
关键词 脑靶向 前药 去甲文拉法辛 葡萄糖转运蛋白1 合成 Brain targeting Prodrug Desvenlafaxine GLUT1 Synthesis
  • 相关文献

参考文献1

二级参考文献3

  • 1U S FDA. FDA approves Pristiq for major depressive disorder (MDD) [EB/OL]. [2008 - 03 - 13 ]. http://www.fda. gov/ eder/rdmt/InternetNME08. htm.
  • 2ZUPANCIC S, SKRABANIA V, Process for preparation of O- desmethylvenlafaxine: WO, 2007/147564 [ P ]. 2007 - 12 - 27.
  • 3NIDDAM-HILDELSHEIM V. Substantially pure O- desmethylvenlafaxine and processes for preparing it: WO, 2007/120923 [P]. 2007 - 10 - 25.

共引文献1

同被引文献25

  • 1姚静,周建平,平其能,卢韵,于力.类透明质酸壳聚糖微乳对小鼠血脑屏障通透性的影响[J].药学学报,2006,41(7):615-618. 被引量:12
  • 2陈钢,侯世祥,胡平,金描真,刘军.经内耳途径靶向脑给药的初步研究[J].药学学报,2007,42(10):1102-1106. 被引量:16
  • 3Huang FY, Chen W J, Lee WY, et al. In vitro and in vivo evaluation of lactoferrin-conjugated liposomes as a novel carrier to improve the brain delivery [J]. lnt J Mol Sci, 2013,14(2): 2 862.
  • 4Sun W, Xie C, Wang H, et al. Specific role of polysorbate 80 coating on the targeting of nanoparticles to the brain [J]. Biomaterials, 2004,25 (15) : 3 065.
  • 5Tosi G, Vergoni AV, Ruozi B, et al.Sialic acid and glyco- peptides conjugated PLGA nanoparticles for central ner- vous system targeting: In vivo pharmacological evidence and biodistribution[J]./Control Release, 2010,145 ( 1 ) : 49.
  • 6Zhang P, Hu L, Yin Q, et al.Transfen'in-Modified c[RGDtK]- paclitaxel loaded hybrid micelle for sequential blood- brain barrier penetration and glioma targeting therapy[J]. MolPharm,2012,9(6) : 1 590.
  • 7Pang Z, Gao H, Chen J, et al.Intracellular delivery mecha- nism and brain delivery kinetics of biodegradable cationic bovine serum albumin-conjugated polymersomes[J].lnt J Nanomedicine, 2012(7) : 3 421.
  • 8Huang RQ, Qu YH, Ke WL, et al.Efficient gene delivery targeted to the brain using a transferrin-conjugated poly- ethyleneglycol-modified polyamidoamine dendrimers[J]. FASEBJ,2007,21(4):l 117.
  • 9黄容琴,蒋晨,裴元英.乳铁蛋白修饰的脑靶向载基因纳米粒治疗帕金森病的研究[C]//2010年中国药学大会暨第十届中国药师周论文集.天津:中国药学会,天津市人民政府,2010:16.
  • 10He H, Li Y, Jia XR, et al. PEGylated poly (amidoamine) dendrimer-based dual-targeting carrier for treating brain tumors[J]. Biomaterials, 2011,32 ( 2 ) : 478.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部